WallStreetZen

NASDAQ: MRNA
Moderna Inc Stock Ownership

Insider buying vs selling

Have Moderna Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Stephen HogePresident2021-06-145,000$10.90
$54.50kBuy
Stephen HogePresident2021-06-1410,000$0.99
$9.90kBuy
Stephen HogePresident2021-06-145,000$10.90
$54.50kBuy
Stephen HogePresident2021-06-1420,000$213.32
$4.27MSell
Juan AndresChief Technical Operations and Quality Officer2021-06-145,000$213.32
$1.07MSell
Juan AndresChief Technical Operations and Quality Officer2021-06-145,000$12.21
$61.05kBuy
Stephane BancelChief Executive Officer2021-06-1010,000$216.70
$2.17MSell
Stephane BancelChief Executive Officer2021-06-099,000$212.30
$1.91MSell
Juan AndresChief Technical Operations and Quality Officer2021-06-095,000$12.21
$61.05kBuy
Tal Zvi ZaksChief Medical Officer2021-06-095,000$212.30
$1.06MSell

1 of 123

MRNA insiders have sold more MRNA shares than they have bought in the last year
Ownership

MRNA Shareholders

What type of owners hold Moderna Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Noubar Afeyan20.30%81,490,098$16.12BInsider
Baillie Gifford Co11.29%45,337,764$8.97BInstitution
Blackrock Inc5.18%20,803,397$4.12BInstitution
Flagship Pioneering Inc5.13%20,581,016$4.07BInstitution
Vanguard Group Inc4.71%18,919,030$3.74BInstitution
Stephane Bancel3.82%15,319,240$3.03BInsider
Robert Langer2.87%11,509,357$2.28BInsider
Morgan Stanley2.05%8,222,788$1.63BInstitution
Theleme Partners Llp1.57%6,302,056$1.25BInstitution
State Street Corp1.50%6,008,874$1.19BInstitution

1 of 3

Moderna Stock Ownership FAQ

Who owns Moderna?

Moderna (NASDAQ: MRNA) is owned by 51.51% institutional shareholders, 28.38% Moderna insiders, and 20.11% retail investors. Noubar Afeyan is the largest individual Moderna shareholder, owning 81.49M shares representing 20.30% of the company. Noubar Afeyan's Moderna shares are currently valued at $16.50B.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.